Guillain–Barré syndrome: immunopathogenesis and therapeutic targets

Introduction Guillain–Barré syndrome (GBS) is a group of acute immune-mediated disorders in the peripheral nervous system. Both infectious and noninfectious factors are associated with GBS, which may act as triggers of autoimmune responses leading to neural damage and dysfunction.